BiotechTube
GBI Biomanufacturing

GBI Biomanufacturing

Rockville, United States· Est.
gbibio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

GBI Biomanufacturing is a private, revenue-generating CDMO providing end-to-end development and manufacturing services for complex biologics. Founded in 2018 and headquartered in Rockville, Maryland with operational facilities in Florida, the company leverages its 'Single-Source Solution™' platform to support clients from preclinical stages through commercial production. GBI has established credibility through industry awards like BioFlorida's 'Manufacturer of the Year' and strategic partnerships, positioning itself in the high-growth advanced therapeutics CDMO market.

BiologicsCell TherapyGene Therapy

Technology Platform

Integrated 'Single-Source Solution™' CDMO platform covering upstream/downstream process development, cGMP manufacturing for biologics/cell/gene therapies, bioconjugation, aseptic fill/finish, and analytical/regulatory support.

Opportunities

The booming development of complex biologics like ADCs and advanced therapies (cell/gene) creates strong demand for specialized CDMO expertise.
Geographic positioning in Florida offers a cost-competitive U.S.
manufacturing base with state support, appealing to biotechs seeking domestic supply chain security.

Risk Factors

Revenue is highly dependent on the success and timing of client pipelines, creating vulnerability to clinical trial failures.
The company operates in an intensely competitive CDMO landscape and must consistently execute flawlessly under cGMP to avoid reputational damage and regulatory issues.

Competitive Landscape

GBI competes in a fragmented but crowded CDMO market, facing large global players (e.g., Lonza, Catalent) and many niche specialists. Its differentiation lies in a focused expertise on complex biologics/conjugation and an integrated, full-service U.S. platform tailored for small-to-mid-sized biotechs.

More companies in Biologics / Biosimilars →More companies in United States →